Wasabi Method · Clinical reference
Shockwave Therapy
Indications
Understand where treatment may fit. Know where the evidence differs.
Explore clinical uses of focused extracorporeal shockwave therapy (ESWT) and radial pressure wave therapy. This guide helps healthcare professionals, trainees and informed patients connect a diagnosis with the right questions about suitability, technology, evidence and safety.
The essential distinction
An indication starts a clinical decision.
It does not complete one.
A diagnosis on a treatment list does not establish suitability or guarantee benefit. The decision also depends on anatomy, symptom history, tissue integrity, previous care, patient goals and the specific device and protocol.
How to read this guide: The descriptions below are a narrative clinical overview, not a formal GRADE assessment. Inclusion in professional recommendations is not equivalent to regulatory approval, reimbursement eligibility or uniformly positive trial evidence.
01 / Technology
Two modalities. Different treatment fields.
Focused ESWT
Focused systems concentrate acoustic energy within a defined region. Target depth, focal geometry and the structures along the acoustic path influence treatment planning. Selected bone and calcification applications require specialist targeting and protocols.¹
Radial pressure wave therapy
Ballistic radial devices deliver diverging pressure waves, with their greatest amplitude near the applicator. Radial and focused treatments have overlapping uses, but their pressure fields and treatment settings are not interchangeable.²
02 / Musculoskeletal practice
Common clinical applications
Consider the exact diagnosis and studied protocol. Persistent pain alone is not a sufficient treatment target.
Plantar heel pain
Frequently studiedPlantar fasciopathy is a common research and clinical application. Assess the pain source and previous conservative care before considering treatment. Footwear, activity demands and rehabilitation remain relevant to the overall plan.¹˒²
Achilles tendinopathy
Location mattersMidportion and insertional Achilles tendinopathy should be considered separately. Support for treatment cannot be assumed to be equal: the 2025 Delphi paper highlights a lack of supportive review evidence for insertional disease. Progressive tendon loading remains central when appropriate.²
Patellar & quadriceps tendinopathy
Evidence is mixed or limitedPatellar tendinopathy is included in expert recommendations, but systematic-review conclusions have not consistently supported benefit. Quadriceps-specific evidence is smaller. Confirm a tendon-related diagnosis and retain an appropriate loading program.²
Greater trochanteric pain syndrome
A recognized clinical applicationGTPS and gluteal tendon presentations appear in professional recommendations. Identify the likely pain source and consider lumbar referral, joint pathology and compressive loading when planning care.¹
Calcific rotator cuff tendinopathy
Guidance differsThis is a longstanding ESWT application, but recommendations are not uniform. NICE recommends use only in research because efficacy evidence is inadequate, despite no major short-term safety concerns. Discuss the relevant guidance and treatment alternatives.¹˒³
Non-calcific rotator cuff pain
A separate clinical questionDo not transfer findings from calcific disease to non-calcific tendinopathy or broad subacromial pain. Establish the underlying diagnosis and assess for tearing, stiffness, instability or referred symptoms before selecting treatment.
Lateral & medial elbow tendinopathy
Protocol-dependent and variableLateral elbow tendinopathy has a long history of ESWT research, with differing trial results. Medial elbow applications have a smaller evidence base. Consider nearby nerves and distinguish tendon-related pain from other upper-limb causes.
Selected localized conditions
Condition-specific assessmentHand and wrist diagnoses should be evaluated individually. Small treatment targets and nearby superficial nerves make anatomical assessment important. Evidence for one wrist or hand condition does not establish benefit for all localized pain.
Knee osteoarthritis
An evolving evidence baseStudies have investigated pain and function, but treatment protocols vary. Identify whether symptoms are predominantly joint-related, tendon-related or periarticular. Do not describe ESWT as a proven cartilage-regeneration treatment.
Myofascial pain & trigger points
Less standardized evidenceUse requires a defined clinical rationale and reproducible target. Nonspecific pain should prompt assessment rather than automatic treatment, especially when neurological or systemic causes are possible.
03 / Specialist applications
Beyond common tendon presentations
These applications require their own evidence appraisal, training and clinical governance.
Delayed union & nonunion
Selected fracture-healing applications are included in ISMST recommendations. Assess stability, infection, imaging and previous surgery with orthopedic oversight. Bone treatment generally involves focused technology, positioning methods and specialist protocols.¹
Vasculogenic erectile dysfunction
EAU guidance gives a weak recommendation for low-intensity shockwave therapy in selected patients, including some men with mild vasculogenic ED. This does not establish equivalent benefit for radial acoustic-wave devices or every cause of ED. Device, patient selection and local requirements matter.⁴
Pelvic pain & female pelvic applications
Pelvic pain and sexual symptoms have multiple possible causes. Findings from a defined pelvic pain population should not be generalized to all pelvic floor dysfunction or female sexual health concerns. Assess each proposed application independently and communicate uncertainty.
Wounds, scars, neurological & aesthetic care
These are distinct clinical fields, not one evidence category. Some wound and neurological applications appear in professional recommendations; other uses remain experimental. Their inclusion does not validate every marketed claim or routine musculoskeletal protocol.¹
04 / Clinical interpretation
Read the evidence at the right level
| Evidence source | What it can tell you | What it does not establish |
|---|---|---|
| Laboratory or animal study | A possible biological pathway under tested conditions. | Clinical effectiveness or safety for an individual patient. |
| Controlled clinical trial | Outcomes for a defined population, device and protocol. | Equivalent results with every device or diagnosis. |
| Systematic review | A synthesis of eligible studies and their limitations. | Certainty when the included studies are small or inconsistent. |
| Expert consensus | Areas of clinical agreement and practice recommendations. | Proof that every recommended use has strong trial evidence. |
| Regulatory labeling | Permitted device claims and intended use within a jurisdiction. | Universal approval across technologies, professions or countries. |
05 / Patient selection
A practical assessment sequence
- Confirm the diagnosis. Identify the likely pain generator and investigate red flags or uncertain findings.
- Define the target. Assess tissue depth, integrity and nearby anatomical structures.
- Review previous care. Consider rehabilitation, activity modification, medication and prior procedures.
- Screen for safety. Review medical history, pregnancy, malignancy, bleeding concerns, implanted devices and relevant medication.
- Match the technology. Select an appropriate device and indication-specific approach within professional scope.
- Agree on goals. Define meaningful changes in symptoms, function and activity, with realistic expectations.
- Document and reassess. Record parameters, tolerance and outcomes; reconsider the plan when progress or symptoms are unexpected.
06 / Mechanisms & rehabilitation
Biological plausibility is a starting point.
Mechanotransduction, vascular signaling, tissue remodeling and pain modulation are proposed or experimentally observed responses to acoustic exposure. They help frame research questions but do not prove that a particular treatment improves a patient’s condition.
For musculoskeletal presentations, treatment planning should address rehabilitation, functional goals and appropriate loading. Shockwave therapy should not become a substitute for establishing the diagnosis or delivering the rest of the care plan.
07 / Common questions
Frequently asked questions
What does an indication mean?
It means treatment may be considered in a defined clinical situation after assessment. It does not guarantee benefit or confirm that every patient with that diagnosis is suitable.
Are focused ESWT and radial pressure waves interchangeable?
No. Their energy distribution, targeting and device parameters differ. Research findings and protocols must be interpreted for the technology actually studied.
Which conditions are most commonly discussed?
Common applications include plantar heel pain, Achilles and patellar tendon presentations, lateral elbow tendinopathy, GTPS and calcific shoulder tendinopathy. The strength and consistency of evidence differ between them.
Is treatment only used for chronic injuries?
Persistent musculoskeletal conditions are common applications. Bone and other specialist uses require separate assessment; neither an acute nor a chronic label alone establishes eligibility.
Can ESWT support bone healing?
Focused ESWT is used in selected delayed-union and nonunion contexts under specialist care. Fracture stability, imaging and infection assessment remain important.
Is shockwave therapy a standard treatment for all pelvic conditions?
No. Pelvic and sexual health uses differ substantially by diagnosis and technology. Specialized assessment and a clear explanation of the evidence are necessary.
Should treatment be combined with exercise?
For many musculoskeletal conditions, appropriately prescribed loading and rehabilitation remain part of care. Activity advice should reflect the injury, symptoms and treatment plan.
Does inclusion here mean a device is approved for the condition?
No. Professional recommendations, clinical evidence, regulatory labeling and insurance coverage are separate matters. Check the specific device and local requirements.
How quickly should a patient improve?
There is no universal timeline. Agree on realistic review points and meaningful outcomes before treatment, and reassess if symptoms worsen or fail to follow the expected course.
Where can I learn about contraindications?
The Wasabi Method contraindications and safety resource covers treatment-field restrictions, medication precautions and reported adverse events. Individual eligibility still requires clinical assessment.
08 / Sources
Evidence & professional guidance
Source numbers identify selected supporting guidance. This page is an educational overview, not an exhaustive systematic review.
1. International Society for Medical Shockwave Treatment. ISMST recommendations: indications, contraindications and clinical prerequisites.
Read ISMST recommendations →2. Rhim HC, Singh M, Maffulli N, et al. Recommendations for use of extracorporeal shockwave therapy in sports medicine: an international modified Delphi study. Br J Sports Med. 2025;59(18):1287-1301. doi:10.1136/bjsports-2024-109082.
Read the Delphi study →3. National Institute for Health and Care Excellence. Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder. HealthTech guidance HTG645. Published November 23, 2022.
Read NICE guidance →4. European Association of Urology. Guidelines on sexual and reproductive health: management of erectile dysfunction.
Read EAU guidance →Continue your education
Build stronger clinical decisions.
Explore the research, develop your understanding of safety and connect evidence with thoughtful patient selection.
Professional education and general information only. This page does not replace patient assessment, formal training, device instructions, professional judgment or local regulatory requirements. Evidence and permitted uses differ by device, indication and jurisdiction. No treatment outcome is guaranteed.